Capital Flow Monitor · Sponsors · CIK 1749990
Paragon Biosciences Emalex Capital, Inc.
303 N WABASH AVE, CHICACO, IL, 60611 · (847) 715-0606
Pharmaceuticals · Corporation· inc. DELAWARE true
Fit score
—
Offering
$270.0M
Sold
$270.0M
% sold
100.0%
Investors
42
Min investment
$1K
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-07-08 | D/A ·current | 506(b) | $270.0M | $270.0M | 100.0% | 42 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed. Other raises are matched by exact name and show amount sold as last reported.
- Patrick J. Morris — Executive Officer, Chicago, IL
- Jeffrey Aronin — Director, Chicago, IL
-
Antonio Gracias — Director, Chicago, IL
11 other raises
- TBC - The Boring Co $3.2B of $3.42B · 93.5%
- VWR 1.0 L.P. $0 of —
- Valor Compute Infrastructure L.P. $2.65B of —
- Valor CI Blocker Feeder L.P. $2.65B of —
- VCI INTERMEDIATE TOPCO 3 LLC $0 of —
- VCI Intermediate TopCo 2 LLC $0 of —
- VALOR ATREIDES AI I-B L.P. $758.7M of $758.7M · 100.0%
- VALOR ATREIDES AI I L.P. $758.7M of $758.7M · 100.0%
- VFT 1.0 L.P. $0 of —
- VCI INTERMEDIATE TOPCO 1 LLC $0 of —
- Valor Access Fund 1.0 L.P. $0 of —
- Darien Parhad — Executive Officer, Chicago, IL
- Eric Messner — Executive Officer / Director, Chicago, IL
- Jeffrey Dayno — Director, Chicago, IL
- Ricky Sun — Director, Chicago, IL
Placement agents
- Paragon Health Capital, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.